Clinical Trial

Environment, Inflammation and Metabolic Diseases Study

Name: Environment, Inflammation and Metabolic Diseases Study — clinical trial record (NCT07512609)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover new mechanisms underlying the onset and progression of these diseases, and to screen for novel therapeutic targets.

Trial Details

NCT Number	NCT07512609
Lead Sponsor	Qifu Li
Conditions	Endocrine Disease, Metabolic Disorders, Hypertension, Diabetes Mellitus
Enrollment	8,000 participants
Start Date	2020-12-25
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-06